LIXTE BIOTECHNOLOGY HLDGS IN
LIXT·539319301·US·Common Stock·Healthcare - Biotechnology-13D/G
LIXT (LIXTE BIOTECHNOLOGY HLDGS IN) is held by 12 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($4.1M), SCOTIA CAPITAL INC. ($2.1M), GEODE CAPITAL MANAGEMENT, LLC ($1.1M). Net institutional sentiment: Mixed.
12
Holders
$9.5M
Total Value
67% (15)
Consensus
10 buying - 5 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Aug 14, 2026 · Insiders none · Activists Jun 9, 2026 · Congress none
ActivistSEStrategic EP, LLC5.1%Jun 9, 2026
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
413 holders · $667.3B
413 holders · $186.4B
394 holders · $391.5B
392 holders · $97.1B
391 holders · $127.1B
391 holders · $147.4B
389 holders · $77B
385 holders · $209.1B
381 holders · $255.1B
380 holders · $129.4B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer